L-689,660
L-689,660 is a chemical compound that acts as a selective antagonist of the NMDA receptor, a subtype of glutamate receptor in the brain. It is primarily used in scientific research to study the role of NMDA receptors in various neurological processes and disorders.
Chemical Structure and Properties
L-689,660 is a derivative of the amino acid glycine, and its chemical structure is characterized by the presence of a bicyclic ring system. The compound is known for its high affinity and selectivity for the glycine site of the NMDA receptor, which is distinct from the glutamate binding site.
Mechanism of Action
L-689,660 functions as a competitive antagonist at the glycine site of the NMDA receptor. By binding to this site, it inhibits the action of glycine, an essential co-agonist required for the activation of the NMDA receptor. This inhibition results in a decrease in the receptor's activity, which can modulate synaptic plasticity and neurotransmission.
Research Applications
L-689,660 is widely used in neuroscience research to investigate the physiological and pathological roles of NMDA receptors. It has been employed in studies exploring:
- Neuroprotection: L-689,660 has been studied for its potential to protect neurons from excitotoxicity, a process that can lead to cell death in conditions such as stroke and traumatic brain injury.
- Cognitive function: Research has examined the effects of L-689,660 on learning and memory, given the critical role of NMDA receptors in synaptic plasticity and long-term potentiation.
- Psychiatric disorders: The compound has been used to model and study disorders such as schizophrenia, where NMDA receptor dysfunction is implicated.
Pharmacokinetics
The pharmacokinetic profile of L-689,660, including its absorption, distribution, metabolism, and excretion, is an important consideration in its use as a research tool. However, detailed pharmacokinetic data may vary depending on the experimental model and administration route.
Safety and Toxicology
As with many research chemicals, the safety and toxicological profile of L-689,660 is primarily characterized in the context of controlled laboratory settings. Researchers must adhere to appropriate safety guidelines when handling and administering the compound.
Also see
| Pharmacology | ||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| Neuroscience | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD